N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	HS3ST1 Gene (Entity type)	-0.00624673
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CDC25A Gene (Entity type)	-0.0050448026
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Aurora kinase A Protein (Entity type)	IC50
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SPP1 Gene (Entity type)	0.010957249
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Palbociclib; Ibrance Compound (Entity type)	0.3945709764957428
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SFRP4 Gene (Entity type)	-0.005394409
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)-2-methoxybenzoic acid Compound (Entity type)	0.4394584000110626
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	RPS4Y1 Gene (Entity type)	0.005950726
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	POLE2 Gene (Entity type)	-0.0056487327
N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	KIF14 Gene (Entity type)	-0.007036407

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
HS3ST1
Gene (Entity type)
-0.00624673

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CDC25A
Gene (Entity type)
-0.0050448026

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Aurora kinase A
Protein (Entity type)
IC50

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SPP1
Gene (Entity type)
0.010957249

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Palbociclib; Ibrance
Compound (Entity type)
0.3945709764957428

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SFRP4
Gene (Entity type)
-0.005394409

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)-2-methoxybenzoic acid
Compound (Entity type)
0.4394584000110626

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
RPS4Y1
Gene (Entity type)
0.005950726

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
POLE2
Gene (Entity type)
-0.0056487327

N-{2-[(1S,4R)-6-(4-Cyclobutylamino-5-trifluoromethyl-pyrimidin-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl]-2-oxo-ethyl}-acetamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
KIF14
Gene (Entity type)
-0.007036407

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.